[1] Fanali G, di Masi A, Trezza V,et al. Human serum albumin:from bench to bedside[J]. Mol Aspects Med,2012,33(3):209-290.
[2] Mendez CM, McClain CJ, Marsano LS. Albumin therapy in clinical practice[J]. Nutr Clin Pract,2005,20(3):314-320.
[3] Liberati A, Moja L, Moschetti I, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients[J]. Intern Emerg Med,2006,1(3):243-245.
[4] Vincent JL. Resuscitation using albumin in critically ill patients:research in patients at high risk of complications is now needed[J]. BMJ,2006,333(7577):1029-1030.
[5] Zhou T, Lu SH, Liu XF, et al., Review of the rational use and adverse reactions to human serum albumin in the People's Republic of China[J].Patient Prefer Adherence,2013,7:1207-1212.
[6] Vincent JL, Wilkes MM, Navickis RJ. Safety of human albumin-serious adverse events reported worldwide in 1998-2000[J]. Br J Anaesth,2003,91(5):625-630.
[7] Sikuler E, Shapira A, Mor-Yosef S, et al. Rational use of albumin[J]. Harefuah, 2000, 139(5-6):190-193, 246.
[8] Vermeulen LC Jr, Ratko TA, Erstad BL, et al. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions[J]. Arch Intern Med,1995,155(4):373-379.
[9] Suarez JI, Martin RH, Calvillo E, et al. The albumin in subarachnoid hemorrhage (ALISAH)multicenter pilot clinical trial:safety and neurologic outcomes[J]. Stroke,2012,43(3):683-690.
[10] 赵龙姝,雷鸣,时扣荣,等. 不同浓度人血白蛋白对老年脑出血危重患者的疗效研究[J]. 临床急诊杂志, 2015,16(5):373-375.
[11] Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients[J]. Cochrane Database Syst Rev,2011(3):CD000567.
[12] Caironi P, Langer T, Gattinoni L.Albumin in critically ill patients:the ideal colloid[J]. Curr Opin Crit Care,2015,21(4):302-308.
[13] Takahashi I, Ohnuma T, Kavy S, et al. Interaction of human serum albumin with anticancer agents in vitro[J]. Br J Cancer,1980,41(4):602-608.
[14] Gou Y,Yang F,Liang H. Designing prodrugs based on special residues of human serum albumin[J]. Curr Top Med Chem,2016,16(9):996-1008.
[15] 王丹,陈慧,刘丽宏,等. 172例人血清蛋白临床应用合理性调查与分析[J]. 药学实践杂志,2014,32(3):231-234.
[16] Ting YX, Wang B. Investigation and analysis of human serum albumin clinical utilization[J]. Chin pharm J,2010,45(13):1035-1038.
[17] Roberts I, Blackhall K, Alderson P, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients[J]. Cochrane Database Syst Rev, 2011, (11):CD001208.
[18] Saw MM, Chandler B, Ho KM. Benefits and risks of using gelatin solution as a plasma expander for perioperative and critically ill patients:a meta-analysis[J]. Anaesth Intensive Care,2012,40(1):17-32.
[19] Pulimood TB,Park GR. Debate:Albumin administration should be avoided in the critically ill[J]. Crit Care,2000,4(3):151-155.
[20] Finfer S,Bellomo R, Boyce N, et a1.A comparison of albumin and saline for fluid resuscitation in the intensive care unit[J]. N Engl J Med,2004,350(22):2247-2256.